Therefore, it would be interesting to continue the study by including more cases and integrating more genetic alterations such as TP53, YKL40, and NF-1 alterations; this should allow a better classification of glioblastomas in molecular groups [20]. The gene discussed is NF1; the disease is glioblastoma.